Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

  1. Pro, B.
  2. Horwitz, S.M.
  3. Prince, H.M.
  4. Foss, F.M.
  5. Sokol, L.
  6. Greenwood, M.
  7. Caballero, D.
  8. Morschhauser, F.
  9. Wilhelm, M.
  10. Iyer, S.P.
  11. Shustov, A.R.
  12. Wolfson, J.
  13. Balser, B.E.
  14. Coiffier, B.
Revue:
Hematological Oncology

ISSN: 1099-1069 0278-0232

Année de publication: 2017

Volumen: 35

Número: 4

Pages: 914-917

Type: Lettre

DOI: 10.1002/HON.2320 GOOGLE SCHOLAR lock_openAccès ouvert editor